Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape Licensing Revenue Becomes Primary Growth Engine
english technology top
(MENAFN - PR Newswire) HONG KONG and HANGZHOU, China, April 30, 2026 /PRNewswire/ -- Hangzhou Diagens Biotech Co., Ltd. (HKEX: 2526, "Diagens"), a pioneer in medical imaging foundation models, today ... 2026-04-30 01:16:14